Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAMSys Technologies was a prominent provider of Radio Frequency Identification (RFID) hardware and software solutions, specializing in the development of multi-protocol RFID readers. The company's technology was extensively applied within the healthcare and pharmaceutical sectors to enhance supply chain visibility, asset tracking, and patient safety through automated data collection. SAMSys played a pivotal role in the early standardization of RFID protocols, offering middleware and hardware that allowed for the integration of various tag types into a single system. In 2006, the company was acquired by SATO Corporation, a global leader in barcode and RFID labeling, to strengthen SATO's position in the high-performance RFID reader market. Today, its legacy technology continues to influence the tracking and tracing capabilities used in modern healthcare logistics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAMSys Technologies.